A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program
POWERS
Physiology of the Weight Reduced State
4 other identifiers
interventional
205
1 country
3
Brief Summary
The goal of this clinical trial is to determine the physiological basis for the differences in weight regain among adults (25-59 years old) with obesity following participation in a behavioral weight loss program. Eligible participants will undergo a baseline evaluation after which they will enter an up to 20 week behavioral weight loss program with the goal of losing at least 7 percent of their baseline weight within 35 weeks. Participants who meet the weight loss goal will be asked to remain weight stable for 2 weeks after which they will undergo a clinical examination. They will then be observed for 1 year during which they will undergo 2 additional clinical examinations, one 4 months after completing the weight loss program, and the other 12 months after completing the weight loss program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Sep 2023
Typical duration for not_applicable obesity
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 28, 2023
CompletedStudy Start
First participant enrolled
September 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
June 18, 2025
June 1, 2025
3.2 years
February 17, 2023
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Weight change from end of weight stabilization following at least 7 percent weight loss to 52 weeks after weight stabilization following at least 7 percent weight loss
Percentage of lost weight that is regained
End of weight stabilization following at least 7 percent weight loss vs. 52 weeks after weight stabilization following at least 7 percent weight loss
Weight change from end of weight stabilization following at least 7 percent weight loss to 52 weeks after weight stabilization following at least 7 percent weight loss
Weight regained
End of weight stabilization following at least 7 percent weight loss vs. 52 weeks after weight stabilization following at least 7 percent weight loss
Study Arms (1)
Weight loss
OTHERA 37 week behavioral intervention aimed at decreasing energy intake and increasing physical activity.
Interventions
A behavioral lifestyle program, up to 20 weeks in duration, based on interventions shown to be successful for weight loss such as the Diabetes Prevention Program (DPP), Action for Health in Diabetes (Look AHEAD), and Comprehensive Assessment of the Long-term Effects of Reducing Intake of Energy Study (CALERIE). Weekly sessions, led by experienced interventionists, will provide education and behavioral strategies for weight loss focused an energy-reduced diet and physical activity. Participants must meet the following milestones to continue in the study: * ≥ 2% weight loss anytime between 28 and 34 days after the start of the intervention * ≥ 5% weight loss anytime between 140 and 146 days after the start of the intervention * ≥ 7% weight loss by the end of 35 weeks After achieving ≥7% weight loss followed by weight stability, participants are observed, without further intervention, for 52 weeks.
Eligibility Criteria
You may qualify if:
- Age: 25 - \<60 years
- BMI: 30 - \<40 kg/m2 at the first screening visit
- Within 5% of current weight, for the past 6 months at the first screening visit
- Able to participate in ergometry testing
- Has a smart phone, tablet or computer with access to the internet
You may not qualify if:
- If 25-29 years old, \> 5% deviation from maximum weight (excluding weights while pregnant) since age 25 years
- If at least 30 years old, \> 5% deviation from maximum weight (excluding weights while pregnant) in last 5 years or ≥ 10% deviation from maximum weight (excluding weights while pregnant) since age 30 years
- History of pulmonary embolus in the past 6 months
- Cardiovascular disease (e.g. myocardial infarction, stroke, hospitalization for unstable angina, or transient ischemic attack) within the past 6 months
- Current major depressive disorder or history of major depressive disorder within 2 years
- Any regular tobacco or nicotine use in the past year
- Currently engaging in intense physical training or training for a sports event including, but not limited to, a marathon or body building
- Currently pregnant, or less than one-year post-partum or actively planning to become pregnant within the next two years
- Presently classified as being in New York Heart Association Class II or greater or dysrhythmia
- Diabetes (type 1 or 2 - HbA1c ≥ 6.5%, fasting glucose ≥ 126 mg/dL) or currently taking a glucose lowering medication
- Thyroid disease requiring hormones or medication or TSH \< 0.5 or \> 5 mIU/L
- Renal disease requiring dialysis
- Known HIV infection
- ALT or AST greater than 5 times the upper limit of normal or active gall bladder disease
- Significant anemia (Hgb \< 10 g/dL) or thrombocytopenia (platelet count \< 60,000 /mm3)
- +27 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator
- Tufts Universitycollaborator
- Columbia Universitycollaborator
- New York State Psychiatric Institutecollaborator
- Drexel Universitycollaborator
- University of Pennsylvaniacollaborator
- Dartmouth Collegecollaborator
Study Sites (3)
Columbia University Irving Medical Center
New York, New York, 10032, United States
Drexel University
Philadelphia, Pennsylvania, 19104, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Belle, PhD
University of Pittsburgh
- PRINCIPAL INVESTIGATOR
Dympna Gallagher, EdD
Columbia University
- PRINCIPAL INVESTIGATOR
Susan Roberts, PhD
Dartmouth College
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 17, 2023
First Posted
February 28, 2023
Study Start
September 29, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
June 18, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Following the end of data collection. Time frame is determined by the NIDDK.
- Access Criteria
- Access to the data for approved ancillary studies will be through the data coordinating center. Access to the data at the NIDDK-repository will be through the NIDDK data repository's process.
Relevant individual participant data (IPD) will be provided to approved ancillary study investigators. All data will be archived, following the end of the study, at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-supported data repository.